VISTAGEN THERAPEUTICS, INC. Extinguishment of Debt, Amount
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Extinguishment of Debt, Amount of $25.05 million for the 6-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Debt
us-gaap:ExtinguishmentOfDebtAmount · last filed 2017-02-13
- VISTAGEN THERAPEUTICS, INC. extinguishment of debt, amount for the quarter ending 2016-09-30 was $0.00.
- VISTAGEN THERAPEUTICS, INC. extinguishment of debt, amount for the quarter ending 2016-06-30 was $25.05M.
- VISTAGEN THERAPEUTICS, INC. extinguishment of debt, amount for the quarter ending 2016-03-31 was $9.50M.
- VISTAGEN THERAPEUTICS, INC. extinguishment of debt, amount for the quarter ending 2015-12-31 was $0.00.
| Period end | Extinguishment of Debt, Amount 3 month | Extinguishment of Debt, Amount 6 month | Extinguishment of Debt, Amount 7 month | Extinguishment of Debt, Amount 9 month | Extinguishment of Debt, Amount 12 month |
|---|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $25.05M 10-Q · filed 2016-11-14 | $34.55M derived: sum of 3 quarters · filed 2017-02-13 | $34.55M derived: sum of 4 quarters · filed 2017-02-13 | |
| 2016-06-30 | $25.05M 10-Q · filed 2016-08-12 | $34.55M derived: sum of 2 quarters · filed 2017-02-13 | $34.55M derived: sum of 3 quarters · filed 2017-02-13 | ||
| 2016-03-31 | $9.50M derived: 10-Q 12 month − 10-Q 9 month · filed 2017-02-13 | $9.50M derived: sum of 2 quarters · filed 2017-02-13 | $26.70M 10-Q · filed 2017-02-13 | ||
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $17.20M 10-Q · filed 2016-02-16 | |||
| 2015-09-30 | $17.20M 10-Q · filed 2015-11-16 | $17.20M 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |